Search

Begin New Search Topic Health Care Policy Political Geography Europe

11. Brexit and the NHS: Devolution

Author:
Jo Hunt, Paul Laffin, Philippa Whitford, and Chris Deerin
Publication Date:
03-2018
Content Type:
Video
Institution:
UK in a Changing Europe, King's College London
Abstract:
Speakers -Dr Jo Hunt – Reader, Cardiff University -Paul Laffin – EU Public Affairs Manager, British Medical Association -Dr Philippa Whitford – Member of Parliament, Central Ayrshire -Chris Deerin, Contributing editor, New Statesman
Topic:
Health Care Policy, Brexit, and National Health Service (NHS)
Political Geography:
United Kingdom and Europe

12. Paying for Prescription Drugs Around the World: Why Is the U.S. an Outlier?

Author:
Shawn Bishop, David Squires, and Dana O. Sarnak
Publication Date:
10-2017
Content Type:
Special Report
Institution:
The Commonwealth Fund
Abstract:
arious factors contribute to high per capita drug spending in the U.S. While drug utilization appears to be similar in the U.S. and the nine other countries considered, the prices at which drugs are sold in the U.S. are substantially higher. These price differences appear to at least partly explain current and historical disparities in spending on pharmaceutical drugs. U.S. consumers face particularly high out-of-pocket costs, both because the U.S. has a large uninsured population and because cost-sharing requirements for those with coverage are more burdensome than in other countries. Most Americans support reducing pharmaceutical costs. International experience demonstrates that policies like universal health coverage, insurance benefit design that restricts out-of-pocket spending, and certain price control strategies, like centralized price negotiations, can be effective.
Topic:
Health, Health Care Policy, and Drugs
Political Geography:
United States, Europe, and Global Focus

13. The rise of the dual labour market: fighting precarious employment in the new member states through industrial relations (PRECARIR) Country report: Croatia

Author:
Hrvoje Butković and Višnja Samardžija
Publication Date:
05-2016
Content Type:
Working Paper
Institution:
Institute for Development and International Relations (IRMO)
Abstract:
The team of IRMO researchers has published a study about the nonstandard work in Croatia in the period since outbreak of the economic crisis, based on the desk research and the interviews. The study is focused on the activities of the trade unions and employers related to increase of the nonstandard work in the sectors of construction, metal industry, retail trade, public healthcare and agency work. The research was published within the project ‛PRECARIR – The rise of the dual labour market: fighting precarious employment in the new member states through industrial relations’ which IRMO implements as a partner from Croatia while it is coordinated by the Dublin City University (DCU). Together with nine other national studies it was published as a CELSI Research Report at the webpage of the CELSI institute from Bratislava. The study was reviewed by three scientific reviewers, and it will be presented at an international conference concerning the nonstandard work in Ljubljana on the 31st May 2016 and at the final conference of the PRECARIR project in Dublin 20th June 2016.
Topic:
Labor Issues, Health Care Policy, Unions, and Trade
Political Geography:
Europe, Eastern Europe, Croatia, and Southern Europe

14. Antimicrobial Resistance as an Emerging Threat to National Security

Author:
Maxine Builder
Publication Date:
01-2015
Content Type:
Working Paper
Institution:
Atlantic Council
Abstract:
Growing rates of antimicrobial resistance (AMR) pose a threat to public health that could undo many of the medical advances made over the last seventy years, eroding the global medical safety net and posing a significant threat to national security. Diseases once eliminated by a single course of antibiotics show drug resistance, often to several different classes of drugs. Some of the implications of increasing rates of AMR are intuitive, such as longer duration of illness, extended hospital stays, and higher rates of mortality. But other effects of a postantibiotics world are less obvious, such as the inability to perform life-saving operations or the ability for a simple scratch on the arm to kill. Humanity could soon find itself living in a reality in which communicable diseases such as tuberculosis, cholera, pneumonia, and other common infections cannot be controlled. This potentially catastrophic problem still can be abated, and the global health community, including the World Health Organization (WHO), has highlighted AMR as a priority in global health. But all sectors of the international community, not simply those in public health, need to take immediate steps to reverse the current trends and eliminate the systematic misuse of antimicrobial drugs, especially in livestock, and restore the pipeline of new antimicrobial drugs. The significant health and economic costs of AMR are difficult to quantify due to incomplete data that often underreports the extent of the problem, since there are no standard metrics or consensus on methodology to measure rates of AMR. But even the piecemeal statistics that exist paint a bleak picture. In a 2013 report, the US Centers for Disease Control and Prevention (CDC) reports at least two million Americans acquire serious infections to one or more strains of AMR bacteria annually, and at least 23,000 people die of these infections.1 A 2008 study estimated the excess direct costs to the US medical system attributable to AMR infections at $20 billion, with additional estimated productivity losses to be as high as $35 billion.2 With the increase in resistant infections and continuing rise in medical costs, the cost to the American medical system no doubt also has increased. This trend is not a uniquely American problem; it is truly global in scope. The European Union (EU) reports about 25,000 deaths annually due to drug-resistant bacteria, at an overall, combined cost of $2 billion in healthcare costs and productivity losses.3 There were over 14.7 million incidents of moderate-to-severe adverse reactions to antibiotics each year between 2001 and 2005 in China. Of these, 150,000 patients died annually.4 The most recent available data on China estimates that treatment of AMR infections during that same time period cost at least $477 million, with productivity losses of more than $55 million each year.5 A 2005 study of the United Kingdom (UK) found that the real annual gross domestic losses due to AMR were between 0.4 and 1.6 percent.6 Although slightly outdated, this estimate may be a useful guide in assessing the global impact of AMR, and given the trend of increasing resistance, it is likely that the impact will also increase accordingly. That said, it is prudent to repeat that the disparities in the quality of data reporting standards across China, the United States, the United Kingdom, and the European Union make it difficult to directly compare the severity of the impacts AMR has on each entity. The primary cause of AMR globally is antibiotic overuse and misuse, be it from doctors inappropriately prescribing antibiotics to treat viral infections or individuals seeking over-the-counter antibiotics for self-treatment. But another driver, less obvious than overuse in humans, is the use of antimicrobials in livestock, and the ratio of use in animals as compared to humans is astounding. In the United States, about 80 percent of all antibiotics are consumed in either agriculture or aquaculture. Generally, these drugs are administered to livestock as growth promoters and are medically unnecessary. Resistance in livestock quickly spreads to humans, and many community-acquired infections are the result of a contaminated food supply. Although most infections are acquired in the community, most deaths attributed to resistant infections occur in healthcare settings, and healthcare-acquired (or nosocomial) infections are another driver of AMR. At this point, AMR does not pose an immediate and direct threat to national security. Rather, this is a creeping global security crisis. If current trends continue, these drugs upon which the world relies will lose effectiveness. The gains made in fighting infectious diseases will be reversed, and a wide range of routine surgeries and easily treatable infections will become much more dangerous and deadly. This will cause the health of the world's working population to deteriorate, and the economic productivity and social cohesion of the globe to decline. At any time, a “black swan” event—triggered by an outbreak of drug-resistant tuberculosis, cholera, or pneumonia, for example—could prove catastrophic, endangering the fabric of societies and our globalized economy, forcing a stop to international trade and travel to prevent further spread. The issue of AMR is a tragedy of the commons in which individual incentives lead to the overuse and eventual destruction of a shared resource. International cooperation is required to walk back from this ledge and avoid a postantibiotics world, even though it is impossible to completely reverse the damage already done.
Topic:
Health, National Security, Infectious Diseases, and Health Care Policy
Political Geography:
United States, China, United Kingdom, America, and Europe

15. Trading Away Access to Medicines - Revisited: How the European trade agenda continues to undermine access to medicines

Author:
Sophie Bloemen, Tessel Mellema, and Leïla Bodeux
Publication Date:
09-2014
Content Type:
Policy Brief
Institution:
Oxfam Publishing
Abstract:
The failure of the current pharmaceutical research and development (R) system is revealed by the World Health Organization (WHO) alert about the lack of effective medicines to address antimicrobial resistance, and the absence of a treatment for the deadly Ebola virus that is ravaging communities in West Africa at the time of writing.
Topic:
Health, International Trade and Finance, and Health Care Policy
Political Geography:
Europe

16. New Approaches to Global Health Cooperation: Perspectives from Brazil

Author:
Katherine E. Bliss, Paulo Buss, and Felix Rosenberg
Publication Date:
09-2012
Content Type:
Working Paper
Institution:
Center for Strategic and International Studies
Abstract:
On November 7, 2011, the Global Health Policy Center of the Center for Strategic and International Studies (CSIS) in Washington, D.C., in partnership with the Fiocruz Center for Global Health (CRIS) in Rio de Janeiro, Brazil, hosted a seminar entitled “New Approaches to Global Health Cooperation.” The event, which took place in Rio de Janeiro, assembled health policy researchers and practitioners from Brazil, Europe, the United States, and sub - Saharan Africa to examine emerging practices in global health co operation. Issues considered included the factors driving greater international engagement on public health challenges, the growing trend of trilateral cooperation, and the role of the BRICS (Brazil, Russia, India, China, and South Africa) and South - South activities in expanding international cooperation on global health. Over the course of the day - long meeting, speakers and audience members examined the reasons for the overall expansion of funding and programming for overseas global health activities durin g the past decade; considered the factors that underpin Brazil's increasing focus on global health as an area of bilateral and multilateral outreach; reviewed the characteristics of successful trilateral cooperation efforts; and debated the future of multi country engagement on health.
Topic:
Development, Emerging Markets, Health, and Health Care Policy
Political Geography:
Africa, Russia, United States, China, Europe, Washington, India, South Africa, Brazil, and Latin America

17. Travelling for health: The potential for medical tourism

Author:
Ana Nicholls
Publication Date:
10-2011
Content Type:
Working Paper
Abstract:
Market size: Medical tourism is not new, but it is growing. Global shift: The flow of travel from developed to developing world. Marketing: How developing countries are targeting the industry. EIU ranking: Why some countries are better placed to benefit than others. US, Europe and Asia trends: The effect of healthcare reforms, budget cuts, and growing wealth. The barriers: The need to harmonise standards and regulations.
Topic:
Globalization, Health, and Health Care Policy
Political Geography:
Europe and Asia

18. Consumer-Directed Home and Community Services Programs in Five Countries: Policy Issues for Older People and Government

Author:
Alison Evans Cuellar, Jane Tilly, and Joshua M. Wiener
Publication Date:
10-2000
Content Type:
Working Paper
Institution:
Urban Institute
Abstract:
A major innovation in long-term care for elderly persons in the United States and Europe is the development of consumer-directed home care. These governmental programs give consumers, rather than home care agencies, control over who provides services and how these services are delivered. Typically, consumer-directed programs allow the consumer to hire, train, supervise, and fire the home care worker. In some programs, beneficiaries receive cash payments enabling them to purchase the services they want. In contrast, traditional home care programs rely on public or private agencies to supply and supervise the workers who serve program beneficiaries.
Topic:
Economics, Human Welfare, and Health Care Policy
Political Geography:
United States, Europe, France, Germany, Netherlands, and Austria